Comparative effectiveness of single versus multiple tablet antiretroviral therapy regimens in clinical HIV practice

    loading  Checking for direct PDF access through Ovid

Abstract

We determined risk of virologic failure (VF) in individuals initiating tenofovir/emtricitabine/efavirenz as single versus multiple tablet regimens (MTR). We found no significant difference in the risk of VF, though did observe a trend toward more VF and M184 V mutations among persons initiating MTR. Temporal trends in care may have confounded results.

Related Topics

    loading  Loading Related Articles